There are a number of medication benefits covered under the Program for which limitations on their coverage apply.
Please note that the following limitations apply to all benefit brands in the drug category specified.
For beneficiaries who require product(s) in any of the listed categories but do not meet the specified limitations, prior approval is required under the special authorization process.
Coverage is limited as indicated for the following medications:
Coverage is limited to 1 aerochamber per patient once in a 365 day period.
The Intervention Code MR may be used to replace an aerochamber that is lost, broken or stolen. Documentation for use of this code must be noted on the original prescription. If documentation cannot be produced during audit activity, the claim will be considered not validated and will be recovered.
For chemotherapy patients only, the Program covers compounded versions of chlorhexide 0.12% mouthwash. This compound contains chlorhexidine gluconate, flavouring, sweetener, and water. Documentation of chemotherapy should be noted on the original hardcopy (i.e. first fill or when logged) or original prescription by the Pharmacist if not already noted by the Physican.
Coverage is limited as indicated for the following medication:
Coverage of glucose test strips is restricted to:
Glucose test strips are subject to a maximum of 2500 test strips per 365 day period (starting the date of first claim for test strips) for all beneficiaries. If a beneficiary exceeds this amount, (s)he is required to submit a letter to the Program from the physician indicating the number of times a day they are required to test. A special authorization will be entered in the system.
Coverage is limited as indicated for the following medication:
Coverage is limited as indicated for the following medication:
These products are limited to women 50 years of age or younger.
These products are limited to female beneficiaries.
Coverage is limited as indicated for the following medication:
Coverage is limited as indicated for the following medication:
Please note that for patients who require product(s) in any of the listed categories and yet do not meet the specified limitations, consideration will be given to provide the product under special authorization on receipt of supportive information from the prescribing physician to the Department of Health and Community Services.